Skip to content

Frailty Outcomes And Risk With Alzheimer's Related Dementia

Association Between Decline in Functional Ability and Frailty in Community-dwelling Older Adults Living With Alzheimer's Dementia

Status
Enrolling by invitation
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06570109
Acronym
FORWARD
Enrollment
130
Registered
2024-08-26
Start date
2024-08-22
Completion date
2027-09-01
Last updated
2025-11-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Alzheimer Disease

Brief summary

The primary aim of this study is to investigate the association between frailty as defined by the Fried Frailty Phenotype and risk of functional decline in patients with Alzheimer's dementia. The hypothesis is that frailty is associated with greater functional decline in community-dwelling older people with Alzheimer's dementia compared to those without frailty. Secondary aims include investigation of long-term risk of institutionalization (through administrative follow-up) and trajectories of assessment components in future assessment. The study is designed as a prospective cohort study. Participants in the study will undergo an assessment battery at baseline, 1 years of follow-up, and administrative follow-up for 5 years. Participants will be recruited from patients of the Unit of Dementia at Aalborg University Hospital within 3 months of dementia diagnosis. The time frame of 3 months after diagnosis was chosen to ensure that cognitive assessment in the Unit of Dementia was reflective of patient's cognitive level and thereby ability to consent at inclusion. Patients will be eligible for inclusion if they are 65 years or older, have a diagnosis of mild or moderate Alzheimer's or mixed (Alzheimer's and vascular) dementia, live at home, and are able to walk 5 meters independently of other people (walking aids will be allowed). The severity of dementia will be defined according to score on the Mini Mental State Examination (MMSE) as it has done in other studies. According to this definition a MMSE score between 20-30 indicates mild Alzheimer's dementia and a MMSE score from 15-19 indicates moderate dementia. People with moderately severe and severe Alzheimer's dementia defined as MMSE score below 15 will not be eligible to participate.

Interventions

OTHERFrailty

defined as weigh loss (\>4.5 kg in one year), exhaustion, slow gait speed (below 20th percentile for sex and height), weakness (handgrip strength below 20th percentile for sex and BMI), and low physical activity (by the Physical Activity Scale for the Elderly). The presence of three or more out of five criteria is defined as frailty while one to two criteria is prefrailty

Sponsors

Aalborg University Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
65 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Diagnosis of Alzheimers Dementia * MMSE \> 14 * Age \>= 65 * Not living in institution * Able to walk 5m without assistence (walking aids accepted)

Exclusion criteria

* No available caregiver/proxy * Unable to give informed consent as judged by caregiver/proxy or researcher * Time from diagnosis \> 3 months

Design outcomes

Primary

MeasureTime frameDescription
Caregiver IADL Change1 yearDefined by caregiver reported ADL performance on the Functional Activities Questinnaire
Patient IADL Change1 yearDefined by patient reported ADL performance on the Functional Activities Questinnaire
Caregiver BADL Change1 yearDefined by caregiver reported ADL performance on Barthel ADL scale
Patient BADL Change1 yearDefined by patient reported ADL performance on Barthel ADL scale

Secondary

MeasureTime frameDescription
Nursing home admission5 yearsAdmission to nursing home (time to event)
Mortality5 yearsDeath (time to event)

Countries

Denmark

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026